Case Report: Integrated genomic and immunological assays identify non-coding CFB variants in pneumococcal meningoencephalitis - Summary - MDSpire

Case Report: Integrated genomic and immunological assays identify non-coding CFB variants in pneumococcal meningoencephalitis

  • By

  • J. Barbieur

  • E. D’haenens

  • T. Jarayseh

  • L. Hoste

  • J. Smet

  • S. Lambrecht

  • E. Schiettecatte

  • P. Schelstraete

  • M. De Bruyne

  • F. Haerynck

  • S. J. Tavernier

  • June 16, 2026

  • 0 min

Share

Objective:

To describe a case of autosomal recessive complement factor B (FB) deficiency and identify associated genetic variants, emphasizing the clinical implications.

Key Findings:
  • The patient exhibited absent alternative pathway activity with preserved classical and lectin pathway function.
  • Two CFB variants were identified: c.898-2A>C and c.1168 + 10G>T, both causing aberrant splicing.
  • Functional assays confirmed that AP activity could be restored with recombinant FB, and the patient's clinical outcomes highlight the importance of these findings.
Interpretation:

This case expands the genetic spectrum of FB deficiency to include non-coding variants and emphasizes the importance of integrating functional assays with genomic analyses for diagnosis, with implications for future research.

Limitations:
  • The study is based on a single case, limiting generalizability; larger cohort studies are needed.
  • Long-term outcomes and the full impact of the identified variants on immune function require further investigation.
Conclusion:

The findings highlight the critical role of advanced genomic and immunological analyses in diagnosing rare inborn errors of immunity.

Original Source(s)

Related Content